Algert Global LLC Pro Qr Therapeutics N.V. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.0 $361 - $645	-645 Reduced 5.7%	10,665 $8,000
Q1 2022 May 16, 2022	BUY	$0.9 - $8.39 $10,179 - $94,890	11,310 New	11,310 $10,000
Q3 2021 Nov 15, 2021	SELL	$5.16 - $8.47 $58,308 - $95,711	-11,300 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.14 - $9.22 $46,782 - $104,186	11,300 New	11,300 $75,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $191M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.